Pharming Group NV (PHAR) — Net Asset Momentum
Pharming Group NV (PHAR) recorded a net asset momentum of 25.3% as of December 2025, with net assets of $277.02 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Pharming Group NV shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Pharming Group NV Net Asset Momentum (2005–2025)
This chart tracks Pharming Group NV's year-over-year net asset growth across 21 annual reporting periods from 2005 to 2025. The most recent momentum reading is +25.3%, with net assets of $277.02 Million USD as of December 2025. For live market cap and overall valuation, see PHAR market cap overview.
Annual Net Asset History for Pharming Group NV (2005–2025)
The table below shows the complete annual net asset history for Pharming Group NV from 2005 to 2025, covering 21 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible net worth ratio of Pharming Group NV to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $277.02 Million | $499.81 Million | $222.79 Million | ▲ +25.3% |
| 2024 | $221.06 Million | $399.99 Million | $178.92 Million | ▲ +1.0% |
| 2023 | $218.78 Million | $462.85 Million | $244.07 Million | ▲ +6.9% |
| 2022 | $204.64 Million | $425.80 Million | $221.16 Million | ▲ +6.1% |
| 2021 | $192.92 Million | $397.31 Million | $204.40 Million | ▲ +28.5% |
| 2020 | $150.16 Million | $342.55 Million | $192.39 Million | ▲ +27.9% |
| 2019 | $117.39 Million | $255.91 Million | $138.53 Million | ▲ +66.2% |
| 2018 | $70.64 Million | $245.45 Million | $174.81 Million | ▲ +213.2% |
| 2017 | $22.56 Million | $199.38 Million | $176.82 Million | ▼ -21.9% |
| 2016 | $28.89 Million | $133.34 Million | $104.45 Million | ▲ +10.8% |
| 2015 | $26.06 Million | $63.06 Million | $37.00 Million | ▼ -28.2% |
| 2014 | $36.29 Million | $67.75 Million | $31.46 Million | ▲ +424.6% |
| 2013 | $6.92 Million | $43.37 Million | $36.45 Million | ▲ +168.4% |
| 2012 | $-10.12 Million | $22.28 Million | $32.40 Million | ▼ -557.2% |
| 2011 | $-1.54 Million | $32.01 Million | $33.55 Million | ▼ -111.5% |
| 2010 | $13.43 Million | $49.59 Million | $36.16 Million | ▼ -29.6% |
| 2009 | $19.07 Million | $80.07 Million | $60.99 Million | ▲ +9.3% |
| 2008 | $17.45 Million | $93.40 Million | $75.96 Million | ▼ -65.5% |
| 2007 | $50.58 Million | $166.72 Million | $116.14 Million | ▼ -23.1% |
| 2006 | $65.78 Million | $104.37 Million | $38.59 Million | ▲ +93.3% |
| 2005 | $34.04 Million | $40.96 Million | $6.93 Million | — |